Dr. David Akhavan
Claim this profileUniversity of Kansas Medical Center
Studies Stereotactic Body Radiation Therapy
Studies Liver Cancer
5 reported clinical trials
8 drugs studied
Area of expertise
1Stereotactic Body Radiation Therapy
metastatic
non-metastatic
2Liver Cancer
Stage III
Stage IV
Affiliated Hospitals
Clinical Trials David Akhavan is currently running
SBRT
for Liver Cancer
This trial will provide the maximum tolerated dose for radiation therapy for liver tumors and describe the toxicity profile using the vGRID therapy technique. Based on trials using this type of radiation in other cancers demonstrating low toxicity rates even with very high radiation doses and high efficacy, it is likely that vGRID therapy in this trial will be well tolerated and allow dose escalation beyond currently common doses for liver tumors.
Recruiting1 award N/A
Nivolumab + Radiosurgery
for Recurrent Meningioma
This trial studies how well nivolumab and stereotactic radiosurgery, with or without ipilimumab, work in treating patients whose grade II-III meningioma has returned. The treatment aims to boost the immune system to fight cancer and use precise radiation to shrink the tumor. Nivolumab and ipilimumab are immune checkpoint inhibitors that have shown promise in treating various cancers, including brain metastases from melanoma.
Recruiting1 award Phase 1 & 210 criteria
More about David Akhavan
Clinical Trial Related2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments David Akhavan has experience with
- GC4711
- Placebo
- VGRID
- Ipilimumab
- Nivolumab
- Stereotactic Radiosurgery
Breakdown of trials David Akhavan has run
Stereotactic Body Radiation Therapy
Liver Cancer
Hepatocellular Carcinoma
Non-Small Cell Lung Cancer
Non-Metastatic
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Akhavan specialize in?
David Akhavan focuses on Stereotactic Body Radiation Therapy and Liver Cancer. In particular, much of their work with Stereotactic Body Radiation Therapy has involved metastatic patients, or patients who are non-metastatic.
Is David Akhavan currently recruiting for clinical trials?
Yes, David Akhavan is currently recruiting for 2 clinical trials in Kansas City Kansas. If you're interested in participating, you should apply.
Are there any treatments that David Akhavan has studied deeply?
Yes, David Akhavan has studied treatments such as GC4711, Placebo, vGRID.
What is the best way to schedule an appointment with David Akhavan?
Apply for one of the trials that David Akhavan is conducting.
What is the office address of David Akhavan?
The office of David Akhavan is located at: University of Kansas Medical Center, Kansas City, Kansas 66160 United States. This is the address for their practice at the University of Kansas Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.